Showing results (221-230 of 258) with videos related to
Sort By:
Pageof 26
Acta Dermato-Venereologica|May 6, 2024
Targeted Combined Endpoint Improvement in Patient and Disease Domains in Atopic Dermatitis: A Treat-to-Target Analysis of Adults with Moderate-to-Severe Atopic Dermatitis Treated with UpadacitinibShawn G Kwatra, Marjolein De Bruin-Weller, Jonathan I Silverberg, et al.Dermatology and Therapy|October 24, 2025
Roflumilast Cream 0.3% in Patients with Chronic Plaque Psoriasis: Pooled PASI and PASI-HD Results from the DERMIS Phase III TrialsKim A Papp, James Q Del Rosso, Mark G Lebwohl, et al.The British Journal of Dermatology|December 11, 2025
Topical Steroid Withdrawal (TSW) Syndrome: Developing Diagnostic Criteria through a Modified Delphi MethodCynhia Hsu, Lily Guo, Derrick Adams, et al.Journal of the American Academy of Dermatology|July 16, 2016
Efficacy and safety of crisaborole ointment, a novel, nonsteroidal phosphodiesterase 4 (PDE4) inhibitor for the topical treatment of atopic dermatitis (AD) in children and adultsAmy S Paller, Wynnis L Tom, Mark G Lebwohl, et al.Pediatric Dermatology|March 7, 2013
Therapeutic patient education in children with atopic dermatitis: position paper on objectives and recommendationsSébastien Barbarot, Claire Bernier, Mette Deleuran, et al.The Journal of Clinical and Aesthetic Dermatology|December 19, 2025
Nemolizumab Demonstrates Marked Efficacy in Challenging Chronic Pruritus: A Real-world Multicenter Case SeriesDiego Ruiz Dasilva, Alondra Soto-González, Nicholas K Mollanazar, et al.Pediatric Dermatology|February 21, 2025
Efficacy and Safety of Once-Daily Roflumilast Cream 0.05% in Pediatric Patients Aged 2-5 Years With Mild-to-Moderate Atopic Dermatitis (INTEGUMENT-PED): A Phase 3 Randomized Controlled TrialLawrence F Eichenfield, Rocco Serrao, Vimal H Prajapati, et al.Dermatology and Therapy|August 9, 2024
Patients with Moderate-to-Severe Atopic Dermatitis Maintain Stable Response with No or Minimal Fluctuations with 1 Year of Lebrikizumab TreatmentJonathan I Silverberg, Andreas Wollenberg, Linda Stein Gold, et al.Journal of Drugs in Dermatology : JDD|July 2, 2024
Appearance Dissatisfaction and Body Dysmorphic Disorder in the Dermatology PatientZane Sejdiu, Erin Stitzlein, Evan A Rieder, et al.Journal of the American Academy of Dermatology|December 21, 2024
The association between obesity and efficacy of psoriasis therapies: An expert consensus panelJoshua Burshtein, April Armstrong, May Chow, et al.Pageof 26